Scarica l'app Stockscreener
14.65
1.88%
0.27
Dopo l'orario di chiusura:
14.66
0.010
+0.07%
Precedente Chiudi:
$14.38
Aprire:
$14.21
Volume 24 ore:
234.68K
Relative Volume:
0.97
Capitalizzazione di mercato:
$375.66M
Reddito:
-
Utile/perdita netta:
$11.77M
Rapporto P/E:
25.32
EPS:
0.5785
Flusso di cassa netto:
$-19.23M
1 W Prestazione:
+18.82%
1M Prestazione:
+5.24%
6M Prestazione:
-17.00%
1 anno Prestazione:
-64.94%
Intervallo 1D:
$13.85
$14.78
Intervallo di 1 settimana:
$12.34
$15.66
Portata 52W:
$11.87
$48.31
Tourmaline Bio Inc Stock (TRML) Company Profile
Nome
Tourmaline Bio Inc
Settore
Industria
Telefono
646-481-9832
Indirizzo
27 WEST 24TH STREET, NEW YORK
Confronta TRML con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
14.65 | 375.66M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 128.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.83 | 81.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.00 | 34.69B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.07 | 30.17B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
242.66 | 26.02B | 3.32B | -860.46M | -1.04B | -8.32 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-06 | Iniziato | Wedbush | Outperform |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-11-11 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-15 | Iniziato | Jefferies | Buy |
| 2023-12-04 | Ripresa | H.C. Wainwright | Buy |
| 2023-11-17 | Iniziato | Truist | Buy |
| 2023-10-31 | Iniziato | Guggenheim | Buy |
| 2023-10-25 | Iniziato | Piper Sandler | Overweight |
| 2022-10-20 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Mostra tutto
Tourmaline Bio Inc Borsa (TRML) Ultime notizie
Wedbush Forecasts Tourmaline Bio FY2024 Earnings - Defense World
Tourmaline Bio (NASDAQ:TRML) Research Coverage Started at Wedbush - Defense World
Rhumbline Advisers Has $722,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio rises as Wedbush initiates with Outperform - MSN
This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - NewsBreak
Wedbush Initiates Coverage on Tourmaline Bio With Outperform Rating, $42 Price Target - Marketscreener.com
Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target -March 06, 2025 at 07:22 am EST - Marketscreener.com
We Tested Over 25 Curling Irons. These 13 Are the Best - MarieClaire.com
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025 - The Manila Times
Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers - The Manila Times
3 Reasons to Buy American Express Stock Like There's No Tomorrow - The Globe and Mail
When and Where to Catch Tourmaline Bio's Next Investor Presentation - StockTitan
Brokers Set Expectations for Tourmaline Bio FY2024 Earnings - MarketBeat
Truist maintains $74 target on Tourmaline Bio stock, reiterates buy By Investing.com - Investing.com UK
Lifesci Capital Predicts Tourmaline Bio FY2024 Earnings - Armenian Reporter
Financial Survey: X4 Pharmaceuticals (NASDAQ:XFOR) & Tourmaline Bio (NASDAQ:TRML) - Defense World
Tourmaline Bio (NASDAQ:TRML) Coverage Initiated by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Tourmaline Bio (TRML) with Outperform Recommendation - MSN
Talaris Therapeutics stock hits 52-week low at $12.06 By Investing.com - Investing.com Australia
Talaris Therapeutics stock hits 52-week low at $12.06 - Investing.com
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Vaxcyte (NASDAQ:PCVX) & Tourmaline Bio (NASDAQ:TRML) Financial Review - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $54.00 Average PT from Brokerages - MarketBeat
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of “Buy” by Analysts - Defense World
ClearOne (NASDAQ:CLRO) Earns Hold Rating from Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Bank of South Carolina (NASDAQ:BKSC) - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Short Interest Up 16.3% in January - MarketBeat
Vulcan Materials (VMC) Q4 Earnings: What To Expect - The Globe and Mail
TrueBlue (TBI) Expected to Announce Earnings on Wednesday - Armenian Reporter
Andersons (ANDE) Projected to Post Quarterly Earnings on Tuesday - Defense World
Leerink Partnrs Comments on Tourmaline Bio FY2024 Earnings - MarketBeat
Leerink Partnrs Weighs in on Tourmaline Bio FY2029 Earnings - MarketBeat
Bleakley Financial Group LLC Purchases 110 Shares of Choice Hotels International, Inc. (NYSE:CHH) - Defense World
In the crowded cardio space, it’s David vs. Goliath for small biotechs - PharmaVoice
Jennison Associates LLC Trims Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - MarketBeat
Tourmaline Bio Inc (TRML) Stock Showcases -13.66% 20-Day Moving Average - The News Heater
TRML’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Solventum Corp (SOLV) Shares Down Despite Recent Market Volatility - The News Heater
Tourmaline Bio Inc (TRML) Becoming More Attractive for Investors - Knox Daily
In the Green: JBDI Holdings Ltd (JBDI) Closes at 0.65, Up/Down 11.02 from Previous Day - The Dwinnex
Closing Bell Recap: E.W. Scripps Co (SSP) Ends at 1.88, Reflecting a 6.82 Upturn - The Dwinnex
Post-Trade Analysis: Celldex Therapeutics Inc (CLDX) Slides -2.11, Closing at 23.15 - The Dwinnex
Market Insights: Avidity Biosciences Inc (RNA)’s Notable Gain of 4.32, Closing at 33.34 - The Dwinnex
Daily Market Movement: Tourmaline Bio Inc (TRML) Sees a 6.37 Increase, Closing at 16.53 - The Dwinnex
Keeping an Eye on Entegris Inc (ENTG) After Insider Trading Activity - Knox Daily
Potential Price Increase for Monster Beverage Corp (MNST) After Recent Insider Activity - Knox Daily
Recent Insider Activity Suggests Potential Gains for Vita Coco Company Inc (COCO) - Knox Daily
Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily
Short Interest in Tourmaline Bio, Inc. (NASDAQ:TRML) Rises By 26.8% - MarketBeat
Tourmaline Bio Inc Azioni (TRML) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):